Why TVTX? Travere Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
TVTX
$44.12+2.00 (+4.75%)
Market ClosedLast close May 1
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.